The clinical test of a vaccine against Ebola did not cause reactions so far
According to an American health official, the first clinical trial of the vaccine for Ebola cure did not cause any side effects.
The test began in the United States in the early part of September with the support of ten volunteers. The vaccine developed by GlaxoSmithKline UK laboratory for many years now has proven effective in previous test performed on monkeys.
"So far, there is no sign indicating severe reactions," said Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) in Senate Committee budget allocations.
In the following days, the vaccine will be given to ten other people aged between 20 and 50 years, clinical healthy. Results will be ready at the end of the year.
Meanwhile, a team from Oxford, UK, will conduct a test of the same vaccine on 60 clinical healthy individuals.
It can thus determine whether the vaccine can lead to a reaction of the immune system to produce enough antibodies to protect against this pathogen.
If, during undergoing tests or future ones, the "vaccine appears safe, he could be available as early as November with priority for health care professionals,", recently announced the World Health Organization.
Find a business